Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...
People with Type 2 diabetes should be concerned with their kidney function, but current testing is woefully insufficient. A ...
An expert task force on Thursday released a new and much-anticipated approach for diagnosing kidney function, saying there is no need for controversial algorithms that consider race in the assessment ...
SGLT2 inhibitors may improve glycaemic control and renal markers without affecting body weight in patients with Prader-Willi syndrome and T2D, but they are tied to an elevated risk for adverse events.
ORLANDO -- Even type 2 diabetes patients with impaired renal function saw improvements in weight and glycemic control with a dual SGLT1/2 inhibitor, according to a meta-analysis. Among nearly 4,000 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback